These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 22885206

  • 1. Doripenem vs meropenem against Pseudomonas and Acinetobacter.
    Goyal K, Gautam V, Ray P.
    Indian J Med Microbiol; 2012; 30(3):350-1. PubMed ID: 22885206
    [Abstract] [Full Text] [Related]

  • 2. Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Pankuch GA, Seifert H, Appelbaum PC.
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):191-7. PubMed ID: 20338710
    [Abstract] [Full Text] [Related]

  • 3. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

  • 4. In Vitro Efficacy of Doripenem against Pseudomonas aeruginosa and Acinetobacter baumannii by E-Test.
    Gilani M, Munir T, Latif M, Rehman S, Ansari M, Hafeez A, Najeeb S, Saad N, Gilani M.
    J Coll Physicians Surg Pak; 2015 Oct; 25(10):726-9. PubMed ID: 26454387
    [Abstract] [Full Text] [Related]

  • 5. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
    McCracken M, Mataseje LF, Loo V, Walkty A, Adam HJ, Hoban DJ, Zhanel GG, Mulvey MR, Canadian Antimicrobial Resistance Alliance (CARA).
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
    [Abstract] [Full Text] [Related]

  • 6. Gastrointestinal selective capacity of doripenem, meropenem, and imipenem for carbapenem-resistant gram-negative bacilli in treated patients with pneumonia.
    Apisarnthanarak A, Kiratisin P, Apisarnthanarak P, Mundy LM.
    Infect Control Hosp Epidemiol; 2011 Apr; 32(4):410-1. PubMed ID: 21460501
    [No Abstract] [Full Text] [Related]

  • 7. Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
    Valenza G, Seifert H, Decker-Burgard S, Laeuffer J, Morrissey I, Mutters R, COMPACT Germany Study Group.
    Int J Antimicrob Agents; 2012 Mar; 39(3):255-8. PubMed ID: 22230334
    [Abstract] [Full Text] [Related]

  • 8. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
    Davies TA, Marie Queenan A, Morrow BJ, Shang W, Amsler K, He W, Lynch AS, Pillar C, Flamm RK.
    J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
    [Abstract] [Full Text] [Related]

  • 9. Carbapenem susceptibility testing errors using three automated systems, disk diffusion, Etest, and broth microdilution and carbapenem resistance genes in isolates of Acinetobacter baumannii-calcoaceticus complex.
    Markelz AE, Mende K, Murray CK, Yu X, Zera WC, Hospenthal DR, Beckius ML, Calvano T, Akers KS.
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4707-11. PubMed ID: 21807971
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of doripenem against Acinetobacter baumannii clinical isolates.
    Marti S, Sánchez-Céspedes J, Alba V, Vila J.
    Int J Antimicrob Agents; 2009 Feb; 33(2):181-2. PubMed ID: 18977642
    [Abstract] [Full Text] [Related]

  • 11. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H.
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.
    Dueñas Díez AI, Bratos Pérez MA, Eiros Bouza JM, Almaraz Gómez A, Gutiérrez Rodríguez P, Miguel Gómez MA, Orduña Domingo A, Rodríguez-Torres A.
    Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728
    [Abstract] [Full Text] [Related]

  • 13. Activities of doripenem against nosocomial bacteremic drug-resistant Gram-negative bacteria in a medical center in Taiwan.
    Dong SX, Wang JT, Chang SC.
    J Microbiol Immunol Infect; 2012 Dec; 45(6):459-64. PubMed ID: 23102796
    [Abstract] [Full Text] [Related]

  • 14. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM, Sawyer AM, Kollef MH.
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [Abstract] [Full Text] [Related]

  • 15. A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study).
    Mustafa M, Chan WM, Lee C, Harijanto E, Loo CM, Van Kinh N, Anh ND, Garcia J.
    Int J Antimicrob Agents; 2014 Apr; 43(4):353-60. PubMed ID: 24636429
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
    Somily AM, Absar MM, Arshad MZ, Al Aska AI, Shakoor ZA, Fatani AJ, Siddiqui YM, Murray TS.
    Saudi Med J; 2012 Jul; 33(7):750-5. PubMed ID: 22821309
    [Abstract] [Full Text] [Related]

  • 17. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].
    Taşbakan MS, Pullukçu H, Ekren PK, Oz AT, Midilli M, Aydemir S, Gürgün A, Başoğlu OK, Bacakoğlu F.
    Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381
    [Abstract] [Full Text] [Related]

  • 18. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
    Riera E, Cabot G, Mulet X, García-Castillo M, del Campo R, Juan C, Cantón R, Oliver A.
    J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of doripenem.
    Sahm D.
    Clin Infect Dis; 2009 Aug 15; 49 Suppl 1():S11-6. PubMed ID: 19619017
    [Abstract] [Full Text] [Related]

  • 20. In vitro sensitivity of Acinetobacter baumannii and Pseudomonas aeruginosa to carbapenems among intensive care unit patients.
    Guzek A, Korzeniewski K, Nitsch-Osuch A, Rybicki Z, Prokop E.
    Adv Exp Med Biol; 2013 Aug 15; 788():109-16. PubMed ID: 23835967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.